Pipeline
| ID | INDIGO-PL-0190 |
|---|---|
| Project Name - (Value) | Social Impact Bond on Diabetes and Diabetic Retinopathy in Armenia |
| Contact - Name - (Value) | Ayan Musa Ahmed |
| Contact - Email - (Value) | zxah@worlddiabetesfoundation.org |
| State of Development - (Value) | Current |
| State of Development - (Source ID's) | source1 |
| Stage of Development - (Value) | Early stage |
| Stage of Development - (Source ID's) | source1 |
| Type of instrument and project - Impact Bond - (Value) | Yes |
| Type of instrument and project - Outcomes Fund - (Value) | No |
| Type of instrument and project - Social Impact Incentives (SIINC) - (Value) | No |
| Type of instrument and project - Social Impact Guarantee - (Value) | No |
| Type of instrument and project - Payment-by-results (no pre-financing) - (Value) | No |
| Type of instrument and project - Technical Assistance and Market-building program (Must involve dedicated grant resources) - (Value) | No |
| (Source ID's) | source1 |
| Part of a larger outcomes-based financing program? - Part of a larger outcomes-based financing program? - (Value) | No |
| Part of a larger outcomes-based financing program? - (Source ID's) | source1 |
| Dates - Expected length of project (years) - (Value) | 3 |
| Dates - (Source ID's) | source1 |
| Purpose and classifications - Social/Developmental challenge - (Value) | Armenia is facing a growing burden of non-communicable diseases (NCDs) including type 2 diabetes (T2DM). In Armenia, more than 110,000 people are officially registered as living with diabetes mellitus (DM) - a threefold increase in just 30 years and their number is expected to surpass 150,000 before 2030. According to global estimates by the International Diabetes Federation (IDF), almost one in two adults (20-79 years old) with DM are unaware of their diabetes status (2021). For Armenia, the proportion of people with undiagnosed diabetes was estimated at 39.6%1 in 2021, indicating that the actual number of people living with diabetes is much higher than official statistics. |
| Purpose and classifications - Expected intervention model - (Value) | The proposed intervention encompasses a comprehensive approach targeting PWD within the selected regions. The intervention will target the entire DM population in these areas for screening sessions, in parallel to identifying individuals aged between 40 and 56 who are not yet registered. The intervention is planned to be carried out in two regions of Armenia - Lori and Armavir, for a target group of 16, 979 people. Out of those 14,930 are diagnosed with DM and 2,049 are non-diagnosed people in working age. The latter is also important, since the analysis of newly diagnosed patients for T2DM reveals that the average age of diagnosis is largely skewed compared to average age of diagnosis in the world. In particular, as per 2020 data the average age at diagnosis in Lori is 58 years old and in Armavir 55 years old, which is 10 years later than international literature suggests. Prevalence of DM and overall eye disease (mainly DR and glaucoma) have been decisive factors in the selection of two regions. |
| Purpose and classifications - Policy sector - Employment and private sector development - (Value) | No |
| Purpose and classifications - Policy sector - Education - (Value) | No |
| Purpose and classifications - Policy sector - Social protection - (Value) | No |
| Purpose and classifications - Policy sector - Criminal justice - (Value) | No |
| Purpose and classifications - Policy sector - Health - (Value) | Yes |
| Purpose and classifications - Policy sector - Agriculture - (Value) | No |
| Purpose and classifications - Policy sector - Environment and climate change - (Value) | No |
| Purpose and classifications - Policy sector - Water, Sanitation and Hygiene - (Value) | No |
| Purpose and classifications - Policy sector - Energy - (Value) | No |
| Purpose and classifications - Policy sector - Humanitarian - (Value) | No |
| Purpose and classifications - Policy sector - Early Childhood Education - (Value) | No |
| Purpose and classifications - Policy sector - Other - (Value) | No |
| Purpose and classifications - Primary SDG goal - (Value) | 3 |
| Purpose and classifications - (Source ID's) | source1 |
| Service users and beneficiaries - Target population - (Value) | People with diabetes (PwD) |
| Service users and beneficiaries - Targeted number of unique service users or beneficiaries (total) - (Value) | 16.979 |
| Service users and beneficiaries - Unit type of targeted service users or beneficiaries - (Value) | Individual |
| Service users and beneficiaries - Country Classification of Service and beneficiaries - Low-income - (Value) | No |
| Service users and beneficiaries - Country Classification of Service and beneficiaries - Lower-middle-income - (Value) | No |
| Service users and beneficiaries - Country Classification of Service and beneficiaries - Upper-middle-income - (Value) | Yes |
| Service users and beneficiaries - Country Classification of Service and beneficiaries - High-income - (Value) | No |
| Service users and beneficiaries - (Source ID's) | source1 |
| Notes - (Value) | Data for this pipeline project was last updated in September 2024 |
| Delivery Locations 1: Service Provision ID - (Value) | deliverylocation1 |
| Delivery Locations 1: Location - Name - (Value) | Armenia |
| Delivery Locations 1: Location - Country - (Value) | AM |
| Sources 1: Id | source1 |
| Sources 1: Name - (Value) | Email correspondence with the World Diabetes Foundation on 10 September 2024 |
| Sources 1: Type - (Value) | Email correspondence |
| Service Provisions 1: Notes | AECP - Armenian EyeCare Project |
| Outcome Payment Commitments 1: Notes | WDF - World Diabetes Foundation |
| Intermediary services 1: Organisation Role Category - (Value) | Other |
| Intermediary services 1: Other Role Description - (Value) | Facilitator |
| Intermediary services 1: Notes | WDF - World Diabetes Foundation |
| Outcome Metrics 1: Id | outcomemetric1 |
| Outcome Metrics 1: Outcome Definition - (Value) | Number of people screened for diabetes and undergone HbA1c tests. |
| Outcome Metrics 2: Id | outcomemetric2 |
| Outcome Metrics 2: Outcome Definition - (Value) | Number of people receiving a personalized health plan. |
| Outcome Metrics 3: Id | outcomemetric3 |
| Outcome Metrics 3: Outcome Definition - (Value) | Number of people receiving any kind of DR treatment and not experiencing any impairment or loss of vision. |
| Outcome Metrics 4: Id | outcomemetric4 |
| Outcome Metrics 4: Outcome Definition - (Value) | Number of patients who do not suffer an aggravation of visual impairment compared to relevant benchmarks (this would be an additional outcome indicator supporting the intervention, not tied to payment). |
| Outcome Metrics 5: Id | outcomemetric5 |
| Outcome Metrics 5: Outcome Definition - (Value) | Number of patients who experience an increase in health-related quality of life (this would be an additional outcome indicator supporting the intervention, not tied to payment). |
| Outcome Metrics 6: Id | outcomemetric6 |
| Outcome Metrics 6: Outcome Definition - (Value) | Observed changes in relevant biomarkers (this would be an additional outcome indicator supporting the intervention, not tied to payment). |